{
    "paper_id": "PMC7217768",
    "metadata": {
        "title": "Optimizing Access to Heart Failure Care in Canada during the COVID-19 Pandemic",
        "authors": [
            {
                "first": "S.A.",
                "middle": [],
                "last": "Virani",
                "suffix": "",
                "email": "svirani@telus.net",
                "affiliation": {}
            },
            {
                "first": "B.",
                "middle": [],
                "last": "Clarke",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "A.",
                "middle": [],
                "last": "Ducharme",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "J.A.",
                "middle": [],
                "last": "Ezekowitz",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "G.A.",
                "middle": [],
                "last": "Heckman",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "M.",
                "middle": [],
                "last": "McDonald",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "L.M.",
                "middle": [],
                "last": "Mielniczuk",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "E.",
                "middle": [],
                "last": "Swiggum",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "H.G.C.",
                "middle": [],
                "last": "Van Spall",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "S.",
                "middle": [],
                "last": "Zieroth",
                "suffix": "",
                "email": null,
                "affiliation": {}
            }
        ]
    },
    "body_text": [
        {
            "text": "In response to this pandemic, HFC have uniquely adapted to their local environment and the population they serve, largely offering consultation through virtual or telehealth. Many still have the ability to see urgent patients in person, but are doing so in a very deliberate and organized manner focussing on the most vulnerable. Management of these patients is challenged by imperatives for physical distancing and/or reduced access to laboratory services.",
            "cite_spans": [],
            "section": "How to transition traditional HFC care into a system of virtual care ::: Introduction",
            "ref_spans": []
        },
        {
            "text": "The pursuit of pharmacotherapy optimization under these circumstances is subject to much debate. So-called, \u2018triple therapy\u2019 for HFrEF dramatically reduces mortality and hospitalization; in clinical trials, these effects are early and substantial. However, safely initiating and up-titrating these medications, as well as newer HFrEF therapies, may necessitate laboratory monitoring, which is challenged in the current environment.",
            "cite_spans": [],
            "section": "How to transition traditional HFC care into a system of virtual care ::: Introduction",
            "ref_spans": []
        },
        {
            "text": "In balancing these competing priorities, our approach is to be practical and pragmatic. Practitioners must be deliberate in their choices related to medication initiation/titration and must not be constrained by traditional HFrEF management algorithms \u2013 this might include treatment with a novel therapy earlier in the patient\u2019s disease course or in the absence of diagnostic imaging data (Table 2\n). Key enablers will include retaining a minimum health human resource compliment to support the virtual HFC\u2019s activity as well as extended public coverage for newer treatments.",
            "cite_spans": [],
            "section": "How to transition traditional HFC care into a system of virtual care ::: Introduction",
            "ref_spans": [
                {
                    "start": 390,
                    "end": 397,
                    "mention": "Table 2",
                    "ref_id": "TABREF1"
                }
            ]
        },
        {
            "text": "How to leverage remote monitoring for those with an established HF care provider and which patients would benefit from being on-boarded to support care at this time",
            "cite_spans": [],
            "section": "How to transition traditional HFC care into a system of virtual care ::: Introduction",
            "ref_spans": []
        },
        {
            "text": "The universal uptake of HF remote monitoring (RM) technologies has been limited in the absence of clear benefit from clinical trials [2]. Lessons learned from earlier efforts have helped provide the framework for an ideal intervention (Supplementary Table S1).",
            "cite_spans": [
                {
                    "start": 134,
                    "end": 135,
                    "mention": "2",
                    "ref_id": "BIBREF1"
                }
            ],
            "section": "How to transition traditional HFC care into a system of virtual care ::: Introduction",
            "ref_spans": []
        },
        {
            "text": "Currently, RM systems allow for continuous ECG recordings, as well as intermittent measurements of heart rate, blood pressure, oxygen saturation, and/or body weight. This can be performed using traditional devices (e.g. tracking vital signs and weight) or wearable technologies (e.g. smart watches, patches, and textiles). Some platforms allow patients to self-monitor their symptoms and engage with their clinician via Bluetooth and other real-time technologies. Tablet or smartphone-based platforms can integrate this data, send alerts to the HF team, and trigger a variety of clinical actions.",
            "cite_spans": [],
            "section": "How to transition traditional HFC care into a system of virtual care ::: Introduction",
            "ref_spans": []
        },
        {
            "text": "RM has increasingly involved data from cardiac implantable electronic devices, which can be used to monitor rhythm, hemodynamics, physiological data, and alert clinicians to early signs of HF decompensation. Perhaps the most promising strategy to date comes from implantable hemodynamic monitoring devices [3] although access to this technology is likely to remain quite limited.",
            "cite_spans": [
                {
                    "start": 307,
                    "end": 308,
                    "mention": "3",
                    "ref_id": "BIBREF2"
                }
            ],
            "section": "How to transition traditional HFC care into a system of virtual care ::: Introduction",
            "ref_spans": []
        },
        {
            "text": "It should be noted that many HFCs lack the infrastructure to support RM. It is also recognized that currently, technology enabled RM tools are not feasible for many highly vulnerable patients, including those with cognitive and/or visual impairment, frailty, limited caregiver support and limited access to (or familiarity with) internet or app-based solutions. As well, many practitioners will require up-skilling to interpret and action the data that emerges.",
            "cite_spans": [],
            "section": "How to transition traditional HFC care into a system of virtual care ::: Introduction",
            "ref_spans": []
        },
        {
            "text": "While a clear benefit of most RM technologies has not been established in all patients with HF, RM may be considered in those subsets who need heart rate or blood pressure assessment during titration of HF therapies, in those with tenuous hemodynamics or deemed to be at risk for decompensation, or in patients who meet indication for ambulatory vital sign or ECG monitoring. Supplementary Table S2 outlines the advantages and limitations for each consideration and the potential applicability in the Canadian context.",
            "cite_spans": [],
            "section": "How to transition traditional HFC care into a system of virtual care ::: Introduction",
            "ref_spans": []
        },
        {
            "text": "The COVID-19 pandemic appears to have accelerated the uptake of RM technology, and may drive solutions for better workflow integration. For now, clinicians should be encouraged to marshal whatever RM resources are available in their local environment to supplement and enhance virtual HF care.",
            "cite_spans": [],
            "section": "How to transition traditional HFC care into a system of virtual care ::: Introduction",
            "ref_spans": []
        },
        {
            "text": "A virtual evaluation for HF as initial assessment is challenging, but not impossible, without previously establishing a clinical baseline and HF etiology. Virtual consultation between a primary care provider and specialist with secure messaging and bidirectional communication has been implemented across multiple jurisdictions in Canada and this has been expanded to include HF sub-specialty consultation as well.",
            "cite_spans": [],
            "section": "How to facilitate access to patients without established linkages to a HF care provider ::: Introduction",
            "ref_spans": []
        },
        {
            "text": "This type of virtual consultation for primary care providers might be enabled by telephone support (e.g. Rapid Access to Consultative Expertise (RACE) in BC) or through a secure online platform (e.g. Building Access to Specialists through eConsultation (BASE) in Ontario). These systems could also facilitate direct-to-patient consultation, especially for low or medium-risk patients who are unattached to a HF clinician, as a broad safety-net.",
            "cite_spans": [],
            "section": "How to facilitate access to patients without established linkages to a HF care provider ::: Introduction",
            "ref_spans": []
        },
        {
            "text": "Patients without established connection to a HF care provider face additional barriers to accurate diagnosis and management of symptoms; this is further amplified in the absence of a primary care provider. Many provinces have physician directories, which serve as central repositories for specialty services (e.g. supports/pathways\" title=\"http://www.gpscbc.ca/what-we-do/practice-supports/pathways\">Pathways in BC). These sites commonly host patient and provider resources, links for clinical decision support tools and have features to enable electronic distribution of educational materials, a key enabling strategy for virtual care.",
            "cite_spans": [],
            "section": "How to facilitate access to patients without established linkages to a HF care provider ::: Introduction",
            "ref_spans": []
        },
        {
            "text": "Home care clients and long-term care residents represent a particularly vulnerable population in whom HF is common. Most Canadian provinces utilize interRAI (International Resident Assessment Instrument) standardized information systems, which can be used to identify those who require urgent HF assessment [4].",
            "cite_spans": [
                {
                    "start": 308,
                    "end": 309,
                    "mention": "4",
                    "ref_id": "BIBREF3"
                }
            ],
            "section": "How to facilitate access to patients without established linkages to a HF care provider ::: Introduction",
            "ref_spans": []
        },
        {
            "text": "By leveraging and strengthening existing linkages between primary care, home and community care and specialist support, we may be able to select patients who are high-risk for decompensation; thus affording an opportunity to prioritize testing and clinical review through established HFC structures and bypass the ER.",
            "cite_spans": [],
            "section": "How to facilitate access to patients without established linkages to a HF care provider ::: Introduction",
            "ref_spans": []
        },
        {
            "text": "Ambulatory HF patients can be stratified into risk groups on the basis of clinical parameters, patient derived data, and objective risk scores (Supplementary Table S3). During the COVID-19 pandemic, it is prudent to consider an individualized approach to the provision of care based on risk assessment as well as advanced care plans. Available risk scores have reasonable predictive accuracy for mortality, however data is lacking for robust risk models related to HF hospitalization [5].",
            "cite_spans": [
                {
                    "start": 485,
                    "end": 486,
                    "mention": "5",
                    "ref_id": "BIBREF4"
                }
            ],
            "section": "How to risk-stratify patients and tailor therapies according to risk ::: Introduction",
            "ref_spans": []
        },
        {
            "text": "We draw particular attention to high-risk patients with advanced HF who may be candidates for mechanical circulatory support or transplantation. It is anticipated that high-risk patients will require, at minimum, an initial in-person visit to develop a care plan; subsequent visits should be performed virtually and supported by a \u2018hospital in the home\u2019 approach including intravenous diuretic administration, where available. In all cases, advanced care planning is critical.",
            "cite_spans": [],
            "section": "How to risk-stratify patients and tailor therapies according to risk ::: Introduction",
            "ref_spans": []
        },
        {
            "text": "Intermediate risk patients should continue to be monitored for HF symptoms using virtual care options. Intensity and frequency should be customized and self-management approaches encouraged where feasible. Medication management including diuretic titration is critical to avoiding fluid congestion.",
            "cite_spans": [],
            "section": "How to risk-stratify patients and tailor therapies according to risk ::: Introduction",
            "ref_spans": []
        },
        {
            "text": "Low risk patients should have continued access to HFC resources as needed, however routine follow-up and testing can be deferred unless there is a change in patient symptoms or status.",
            "cite_spans": [],
            "section": "How to risk-stratify patients and tailor therapies according to risk ::: Introduction",
            "ref_spans": []
        },
        {
            "text": "Crisis management through physical distancing may have unintended consequences on urgent services. Access to care is paramount for many clinical conditions, including HF, where a timeline for decompensation can be clearly articulated. As the pandemic progresses, there will be increasing pressure on the health system as those who have been \u2018waiting it out\u2019 at home with semi-urgent status become urgent or emergent.",
            "cite_spans": [],
            "section": "Conclusion",
            "ref_spans": []
        },
        {
            "text": "As such, public health imperatives that constrain traditional HF service delivery models must be accompanied by rapid system redesign initiatives and be coupled with messaging that encourages the continued use of the health system by individuals with serious conditions, and those requiring access to highly specialized or regional services.",
            "cite_spans": [],
            "section": "Conclusion",
            "ref_spans": []
        }
    ],
    "ref_entries": {
        "TABREF0": {
            "text": "Table 1: COVID-19 specific barriers to accessing HF care\n",
            "type": "table"
        },
        "TABREF1": {
            "text": "Table 2: Considerations for Virtual HF Management\n",
            "type": "table"
        }
    },
    "back_matter": [],
    "bib_entries": {
        "BIBREF0": {
            "title": "",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1016/j.cjco.2020.03.001%20"
                ]
            }
        },
        "BIBREF1": {
            "title": "Comparative effectiveness of transitional care services in patients discharged from the hospital with heart failure: a systematic review and network meta-analysis",
            "authors": [
                {
                    "first": "H.G.C.",
                    "middle": [],
                    "last": "Van Spall",
                    "suffix": ""
                },
                {
                    "first": "T.",
                    "middle": [],
                    "last": "Rahman",
                    "suffix": ""
                },
                {
                    "first": "O.",
                    "middle": [],
                    "last": "Mytton",
                    "suffix": ""
                }
            ],
            "year": 2017,
            "venue": "Eur J Heart Fail",
            "volume": "19",
            "issn": "11",
            "pages": "1427-1443",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF2": {
            "title": "Wireless pulmonary artery pressure monitoring guides management to reduce decompensation in heart failure with preserved ejection fraction",
            "authors": [
                {
                    "first": "P.B.",
                    "middle": [],
                    "last": "Adamson",
                    "suffix": ""
                },
                {
                    "first": "W.T.",
                    "middle": [],
                    "last": "Abraham",
                    "suffix": ""
                },
                {
                    "first": "R.C.",
                    "middle": [],
                    "last": "Bourge",
                    "suffix": ""
                }
            ],
            "year": 2014,
            "venue": "Circ Heart Fail",
            "volume": "7",
            "issn": "",
            "pages": "935-944",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF3": {
            "title": "Derivation and validation of the detection of indicators and vulnerabilities for emergency room trips scale for classifying the risk of emergency department use in frail community-dwelling older adults",
            "authors": [
                {
                    "first": "A.P.",
                    "middle": [],
                    "last": "Costa",
                    "suffix": ""
                },
                {
                    "first": "J.P.",
                    "middle": [],
                    "last": "Hirdes",
                    "suffix": ""
                },
                {
                    "first": "C.M.",
                    "middle": [],
                    "last": "Bell",
                    "suffix": ""
                }
            ],
            "year": 2015,
            "venue": "J Am Geriatr Soc",
            "volume": "63",
            "issn": "4",
            "pages": "763-769",
            "other_ids": {
                "DOI": [
                    "10.1111/jgs.13336"
                ]
            }
        },
        "BIBREF4": {
            "title": "2017 Comprehensive Update of the Canadian Cardiovascular Society Guidelines for the Management of Heart Failure",
            "authors": [
                {
                    "first": "J.A.",
                    "middle": [],
                    "last": "Ezekowitz",
                    "suffix": ""
                },
                {
                    "first": "E.",
                    "middle": [],
                    "last": "O\u2019Meara",
                    "suffix": ""
                },
                {
                    "first": "M.A.",
                    "middle": [],
                    "last": "McDonald",
                    "suffix": ""
                }
            ],
            "year": 2017,
            "venue": "Can J Cardiol",
            "volume": "33",
            "issn": "11",
            "pages": "1342-1433",
            "other_ids": {
                "DOI": [
                    "10.1016/j.cjca.2017.08.022"
                ]
            }
        }
    }
}